Baxter Jumps After Q2 Beat, Boosted 2026 Guidance Reflects Turnaround Progressbenzinga_article·1 hour agoBAX+7.13%
BAX: Q2 sales up 5% to $2.96B; adjusted EPS $0.56; full-year outlook raisedQuartr·5 hours agoBAX+7.13%
Baxter International Inc. Stock Outperforms Competitors On Strong Trading DayMarketWatch Automated·19 hours agoBAX+7.13%
